Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain.

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Biological Psychiatry

• Publication date

  2004-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/J.BIOPSYCH.2004.02.003PMID 15158429
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Brain region and dose effects of an olanzapine/fluoxetine combination on extracellular monoamine concentrations in the rat.

  2004cited by this paper
• Enhancing neuronal plasticity and cellular resilience to develop novel, improved therapeutics for difficult-to-treat depression.

  2003cited by this paper
• Fibroblast growth factors as regulators of central nervous system development and function.

  2003cited by this paper
• MinireviewFinding the Intracellular Signaling Pathways Affected by Mood Disorder Treatments

  2003cited by this paper
• Dopaminergic D2 receptor activation modulates FGF‐2 gene expression in rat prefrontal cortex and hippocampus

  2003cited by this paper
• Electrophysiological effects of acute and chronic olanzapine and fluoxetine in the rat prefrontal cortex.

  2003cited by this paper
• Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression.

  2003cited by this paper
• Activation of the TrkB Neurotrophin Receptor Is Induced by Antidepressant Drugs and Is Required for Antidepressant-Induced Behavioral Effects

  2003cited by this paper
• Antidepressant treatments induce the expression of basic fibroblast growth factor in cortical and hippocampal neurons.

  2002cited by this paper
• Neurobiology of depression.

  2002cited by this paper
• Function and regulation of CREB family transcription factors in the nervous system.

  2002cited by this paper
• 5(S)-Hydroxyeicosatetraenoic Acid Stimulates DNA Synthesis in Human Microvascular Endothelial Cells via Activation of Jak/STAT and Phosphatidylinositol 3-Kinase/Akt Signaling, Leading to Induction of Expression of Basic Fibroblast Growth Factor 2*

  2002cited by this paper
• Synaptic plasticity and mood disorders

  2002cited by this paper
• The phosphoinositide 3-kinase pathway.

  2002cited by this paper
• Brain-Derived Neurotrophic Factor Produces Antidepressant Effects in Behavioral Models of Depression

  2002cited by this paper
• Dopamine Induces a PI3-Kinase-Independent Activation of Akt in Striatal Neurons: A New Route to cAMP Response Element-Binding Protein Phosphorylation

  2002cited by this paper
• Protective effect of dopamine D2 agonists in cortical neurons via the phosphatidylinositol 3 kinase cascade

  2002cited by this paper
• Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway.

  2001cited by this paper
• Developmental and stress-related changes of neurotrophic factor gene expression in an animal model of schizophrenia

  2001cited by this paper
• Neurotrophins: roles in neuronal development and function.

  2001cited by this paper
• Stimulatory role of dopamine on fibroblast growth factor‐2 expression in rat striatum

  2001cited by this paper
• Neurotrophins as synaptic modulators

  2001cited by this paper
• A novel augmentation strategy for treating resistant major depression.

  2001cited by this paper
• Ten years of protein kinase B signalling: a hard Akt to follow.

  2001cited by this paper
• Retracted: Neuroprotection mediated by glial group‐II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol‐3‐kinase pathways

  2001cited by this paper
• 5‐HT2A and D2 receptor blockade increases cortical DA release via 5‐HT1A receptor activation: a possible mechanism of atypical antipsychotic‐induced cortical dopamine release

  2001cited by this paper
• FGF-2 regulation of neurogenesis in adult hippocampus after brain injury

  2001cited by this paper
• Chronic Antidepressant Treatment Increases Neurogenesis in Adult Rat Hippocampus

  2000cited by this paper
• The high molecular weight isoforms of basic fibroblast growth factor (FGF‐2): an insight into an intracrine mechanism

  2000cited by this paper
• Synergistic Effects of Olanzapine and Other Antipsychotic Agents in Combination with Fluoxetine on Norepinephrine and Dopamine Release in Rat Prefrontal Cortex

  2000cited by this paper
• Physical activity and antidepressant treatment potentiate the expression of specific brain-derived neurotrophic factor transcripts in the rat hippocampus.

  2000cited by this paper
• Enhanced cortical dopamine output and antipsychotic-like effects of raclopride by alpha2 adrenoceptor blockade.

  1999cited by this paper
• Neuronal growth cone collapse triggers lateral extensions along trailing axons

  1999cited by this paper
• Neurotrophins and synaptic plasticity.

  1999cited by this paper
• Enhanced Cortical Dopamine Output and Antipsychotic-like Effects of Raclopride by α2 Adrenoceptor Blockade

  1999cited by this paper
• Morphometric evidence for neuronal and glial prefrontal cell pathology in major depression.

  1999cited by this paper
• Fibroblast Growth Factor-2 Activates a Latent Neurogenic Program in Neural Stem Cells from Diverse Regions of the Adult CNS

  1999cited by this paper
• Selective modulation of fibroblast growth factor-2 expression in the rat brain by the atypical antipsychotic clozapine.

  1999cited by this paper
• Neurotrophins and depression.

  1999cited by this paper
• Impaired cerebral cortex development and blood pressure regulation in FGF‐2‐deficient mice

  1998cited by this paper
• Cyclic AMP-dependent regulation of fibroblast growth factor-2 messenger RNA levels in rat cortical astrocytes: comparison with fibroblast growth factor-1 and ciliary neurotrophic factor.

  1996cited by this paper
• Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus

  1996cited by this paper
• Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments

  1995cited by this paper

• Neuritin Controls Axonal Branching in Serotonin Neurons: A Possible Mediator Involved in the Regulation of Depressive and Anxiety Behaviors via FGF Signaling

  2024cites this paper
• The relationship between salivary Fibroblast Growth Factor-2 and cortisol reactivity and psychological outcomes prior to and during the COVID-19 pandemic

  2023cites this paper
• Short-Term Irisin Treatment Enhanced Neurotrophin Expression Differently in the Hippocampus and the Prefrontal Cortex of Young Mice

  2023cites this paper
• Neurotrophic Factors and Dendritic Spines.

  2023cites this paper
• Antidepressant-like effects of trophic factor receptor signaling

  2022cites this paper
• Adult Brain Cytogenesis in the Context of Mood Disorders: from Neurogenesis to the Emergent Role of Gliogenesis.

  2021cites this paper
• Trophic Factors as Potential Therapies for Treatment of Major Mental Disorders.

  2021cites this paper
• The effects of cocaine exposure in adolescence: Behavioural effects and neuroplastic mechanisms in experimental models

  2021cites this paper
• Molecular and Clinical Significance of Fibroblast Growth Factor 2 in Development and Regeneration of the Auditory System

  2021cites this paper
• Neuro-Signals from Gut Microbiota: Perspectives for Brain Glioma

  2021cites this paper
• Growth Factors and Alcohol Use Disorder.

  2020cites this paper
• FGF21 Attenuated LPS-Induced Depressive-Like Behavior via Inhibiting the Inflammatory Pathway

  2020cites this paper
• Editorial: The Fibroblast Growth Factor Signaling Pathway in Metabolic Regulation, Development, Disease, and Repair After Injury

  2020cites this paper
• Anhedonic-like behavior and BDNF dysregulation following a single injection of cocaine during adolescence.

  2020cites this paper
• Clozapine As Transformative Treatment In Bipolar Patients

  2019cites this paper
• NDT_A_227196 2901..2905

  2019cites this paper
• Fibroblast Growth Factors in Depression

  2019cites this paper
• Encapsulated stem cells ameliorate depressive-like behavior via growth factor secretion

  2018cites this paper
• Fibroblast growth factor 2 is necessary for the antidepressant effects of fluoxetine

  2018cites this paper
• The impact of chronic fluoxetine on conditioned fear expression and hippocampal FGF2 in rats: Short‐ and long‐term effects

  2018cites this paper
• The role of fibroblast growth factor 2 in drug addiction

  2018cites this paper
• Cell encapsulation enhances antidepressant effect of the mesenchymal stem cells and counteracts depressive-like behavior of treatment-resistant depressed rats

  2018cites this paper
• Molecular targets of atypical antipsychotics: From mechanism of action to clinical differences

  2018cites this paper
• Serotonin transporter and receptor ligands with antidepressant activity as neuroprotective and proapoptotic agents

  2017cites this paper
• Clozapine as the most efficacious antipsychotic for activating ERK 1/2 kinases: Role of 5-HT2A receptor agonism.

  2017cites this paper
• The Effects of Lithium on FGF 23 Die Wirkung von Lithium auf FGF 23 Inaugural

  2016cites this paper
• Anxiolytic effects of muscarinic acetylcholine receptors agonist oxotremorine in chronically stressed rats and related changes in BDNF and FGF2 levels in the hippocampus and prefrontal cortex

  2016cites this paper
• An assessment of the antidepressant-like properties of erythropoietin in an animal model of depression by Kyla Vanderzwet

  2015cites this paper
• Impact of Lithium Treatment on FGF-23 Serum Concentrations in Depressive Patients

  2014influential citation
• Lamotrigine reduces affective instability in depressed patients with mixed mood and anxiety disorders.

  2014cites this paper
• Serotonin : from mouse models to human disorders

  2014cites this paper
• Universidade Federal de Santa Catarina Centro de Ciências Biológicas Programa de Pós-Graduação em Bioquímica

  2014cites this paper
• Moonlighting Proteins and Protein–Protein Interactions as Neurotherapeutic Targets in the G Protein-Coupled Receptor Field

  2014cites this paper
• he serotonin – BDNF duo : Developmental implications for the ulnerability to psychopathology udith

  2014cites this paper
• Role of the Axonal Initial Segment in Psychiatric Disorders: Function, Dysfunction, and Intervention

  2014cites this paper
• Fluoxetine Upregulates Phosphorylated-AKT and Phosphorylated-ERK1/2 Proteins in Neural Stem Cells: Evidence for a Crosstalk between AKT and ERK1/2 Pathways

  2013cites this paper
• Behavioural and neuroplastic properties of chronic lurasidone treatment in serotonin transporter knockout rats.

  2013cites this paper
• Interplay between pro-inflammatory cytokines and growth factors in depressive illnesses

  2013influential citation
• Modulation of neuronal plasticity following chronic concomitant administration of the novel antipsychotic lurasidone with the mood stabilizer valproic acid

  2013cites this paper
• Implementing Neuronal Plasticity in NeuroAIDS: the Experience of Brain-derived Neurotrophic Factor and other Neurotrophic Factors

  2013cites this paper
• Intracellular pathways of antipsychotic combined therapies: implication for psychiatric disorders treatment.

  2013cites this paper
• ESTUDO DO EFEITO NEUROPROTETOR DA DULOXETINA

  2013cites this paper
• Part I: Catalytic Direct C-H Arylation of Pyrazoles Part II: Toward Modulation of Neuroplasticity with Small Molecules

  2013cites this paper
• The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK‐3 activities

  2013cites this paper
• Chronic administration of duloxetine and mirtazapine downregulates proapoptotic proteins and upregulates neurotrophin gene expression in the hippocampus and cerebral cortex of mice.

  2013cites this paper
• Olanzapine/Fluoxetine

  2012cites this paper
• Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression.

  2012cites this paper
• The administration of olanzapine and fluoxetine has synergistic effects on intracellular survival pathways in the rat brain.

  2012cites this paper
• A study of the functional significance of epidermal growth factor in major depressive disorder

  2012cites this paper
• Stress e depressione: Meccanismi eziopatologici e modulazione farmacologica

  2012cites this paper
• Regulation of System XC- and its Contribution to Cell Death

  2012cites this paper
• The Existence of FGFR1–5-HT1A Receptor Heterocomplexes in Midbrain 5-HT Neurons of the Rat: Relevance for Neuroplasticity

  2012cites this paper
• UNIVERSIDADE DO EXTREMO SUL CATARINENSEUNESC UNIDADE ACADÊMICA DE CIÊNCIAS DA SAÚDEUNASAU PROGRAMA DE PÓSGRADUAÇÃO EM CIÊNCIAS DA SAÚDEPP GCS EFEITOS NEUROQUÍMICOS DA ADMINISTRAÇÃO DE OLANZAPINA E/OU FLUOXETINA EM RATOS WISTAR: IMPLICAÇÕES NO ENTENDIMENTO DA TERAPÊUTICA DA DEPRESSÃO BIPOLAR

  2011cites this paper
• Fibroblast growth factor-2 (FGF2) augmentation early in life alters hippocampal development and rescues the anxiety phenotype in vulnerable animals

  2011cites this paper
• Antistress properties of antidepressant drugs and their clinical implications.

  2011cites this paper
• Inactivation of fibroblast growth factor binding protein 3 causes anxiety-related behaviors.

  2011cites this paper
• Modulation of neuroplastic molecules in selected brain regions after chronic administration of the novel antidepressant agomelatine

  2011cites this paper
• Roles of exogenous and endogenous FGF-2 in animal models of depression

  2011influential citation
• Olanzapine/Fluoxetine

  2010cites this paper
• Neurotrophic Factors and Antidepressant Action: Recent Advances

  2010cites this paper
• Affective processing in major depressive disorder : neuroanatomical correlates of state and trait abnormailities.

  2010cites this paper
• Altered expression of glutamate signaling, growth factor and glia genes in the locus coeruleus of patients with major depression

  2010cites this paper
• Expression and Functions of Fibroblast Growth Factor 2 (FGF-2) in Hippocampal Formation

  2010cites this paper
• Fibroblast growth factors in schizophrenia.

  2010cites this paper
• Antipsychotic drug actions on gene modulation and signaling mechanisms.

  2009cites this paper
• Modulation of Homer1a expression and Homer-mediated signaling in the post-synaptic density by antipsychotics: role of the cortical-subcortical dopamine-glutamate interaction

  2009cites this paper
• Molecular mechanisms underlying synergistic effects of SSRI–antipsychotic augmentation in treatment of negative symptoms in schizophrenia

  2009influential citation
• New approaches to the pharmacological management of major depressive disorder.

  2009cites this paper
• Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression

  2009cites this paper
• Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects.

  2009cites this paper
• Neuronal plasticity: a link between stress and mood disorders.

  2009cites this paper
• Antipsychotic and antidepressant co-treatment: effects on transcripts of inducible postsynaptic density genes possibly implicated in behavioural disorders.

  2009cites this paper
• Fibroblast growth factor‐2 deficiency affects hippocampal spine morphology, but not hippocampal catecholaminergic or cholinergic innervation

  2009cites this paper
• Assessing the Neuronal Serotonergic Target-based Antidepressant Stratagem: Impact of In Vivo Interaction Studies and Knockout Models

  2008cites this paper
• Spotlight on Olanzapine/Fluoxetine in Acute Bipolar Depression

  2008cites this paper
• Stress and cocaine interact to modulate basic fibroblast growth factor (FGF-2) expression in rat brain

  2008cites this paper
• DETA/NONOate, a nitric oxide donor, produces antidepressant effects by promoting hippocampal neurogenesis

  2008cites this paper
• Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons.

  2008cites this paper
• Antipsychotic Drugs: Comparison in Animal Models of Efficacy, Neurotransmitter Regulation, and Neuroprotection

  2008influential citation
• Antidepressant drugs modulate growth factors in cultured cells

  2008cites this paper
• Fluoxetine Enhances Cutaneous Wound Healing in Chronically Stressed Wistar Rats

  2007cites this paper
• Gliogenesis and glial pathology in depression.

  2007cites this paper
• The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior

  2007cites this paper
• Interaction of FGF-2 with IGF-1 and BDNF in stimulating Akt, ERK, and neuronal survival in hippocampal cultures.

  2007cites this paper
• Evidence for neuroprotective effects of antipsychotic drugs: implications for the pathophysiology and treatment of schizophrenia.

  2007cites this paper
• From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission.

  2007cites this paper
• Serotonin and neuronal growth factors – a convergence of signaling pathways

  2007cites this paper
• Neurogenic Actions of Atypical Antipsychotic Drugs and Therapeutic Implications

  2007cites this paper
• Neurotrophins and neuronal plasticity in the action of antidepressants and morphine

  2007cites this paper
• Antidepressant administration modulates neural stem cell survival and serotoninergic differentiation through bcl-2.

  2007cites this paper
• Cell Membrane and Signal Transduction Pathways—Implications for the Pathophysiology of Bipolar Disorders

  2007cites this paper
• Neurotrophic Factors in Etiology and Treatment of Mood Disorders

  2007cites this paper
• Extended characterisation and validation of an animal model of post-traumatic stress disorder : behavioural, molecular and pharmacological studies

  2007cites this paper
• Stress during development: Impact on neuroplasticity and relevance to psychopathology.

  2007cites this paper
• Dynamic regulation of fibroblast growth factor 2 (FGF‐2) gene expression in the rat brain following single and repeated cocaine administration

  2006cites this paper
• The fibroblast growth factor system and mood disorders.

  2006cites this paper
• Possible Mechanisms of Neurodegeneration in Schizophrenia

  2006cites this paper
• Behavioral control of the stressor modulates stress-induced changes in neurogenesis and fibroblast growth factor-2

  2006cites this paper
• Fluoxetine up-regulates expression of cellular FLICE-inhibitory protein and inhibits LPS-induced apoptosis in hippocampus-derived neural stem cell.

  2006cites this paper
• Optimierung der antipsychotischen Therapie mit Olanzapin durch Augmentationsstrategien

  2006cites this paper